Director dealings: Syncona chair acquires shares
(Sharecast News) - Syncona revealed on Tuesday that chairperson Melanie Gee had acquired 26,500 ordinary shares in the FTSE 250-listed life sciences investor.
Read moreTo deliver superior long-term capital appreciation from investments in life science businesses, leading long-only and alternative investment funds and managed accounts across multiple asset classes.
Find out MoreFri, 26th Mar 2021 07:59
(Sharecast News) - Syncona revealed on Tuesday that chairperson Melanie Gee had acquired 26,500 ordinary shares in the FTSE 250-listed life sciences investor.
Read more(Sharecast News) - Syncona updated the market on its trading amid the Covid-19 coronavirus pandemic on Monday, reporting that since the start of the outbreak, it had taken measures to protect its employees, primarily centred around remote working, to help ensure it could continue to operate with as minimal disruption as possible.
Read moreSyncona Expects Delays In Clinical Trials Due To Virus Disruption
Read moreDIRECTOR DEALINGS SUMMARY: Plus500 Team Spend GBP14 Million On Shares
Read moreDIRECTOR DEALINGS SUMMARY: IAG Chair And Director Spend EUR1.2 Million
Read more(Sharecast News) - Rentokil: Jefferies upgrades to buy with a target price of 620p.
Read moreSyncona Investee Presents Positive Data For Fabry, Gaucher Studies
Read moreSyncona Investee Freeline Reports Positive Data From FLT180a Trial
Read more(Sharecast News) - Healthcare investment company Syncona updated the market on the quarter ended 31 December on Tuesday, reporting that its had expanded, invested in and advanced its portfolio in the period.
Read moreSyncona Net Assets Rise Slightly In "Productive" Third Quarter
Read moreSyncona, Arix Note New Data From Autolus Trial Of AUTO3 Cell Therapy
Read moreSyncona, Arix Note Pricing Of Public Offering By Autolus Therapeutics
Read more(Sharecast News) - Healthcare investment company Syncona announced on Thursday that its portfolio company, Autolus Therapeutics, had confirmed the pricing of its underwritten public offering in the United States.
Read moreSyncona Commits USD80 Million Investment Into Freeline Therapeutics
Read more(Sharecast News) - Healthcare company Syncona said it had made an $80m (£61.1m) funding commitment to biotech company Freeline.
Read more